[1]
|
Chen, C.T. and Lin, J.C. (2013) Elephantiasic Pretibial Myxoedema. Indian Journal of Medical Research, 137, 568.
|
[2]
|
Fatourechi, V., Pajouhi, M. and Fransway, A.F. (1994) Dermopathy of Graves Disease (Pretibial Myxedema): Review of 150 Cases. Medicine (Baltimore), 73, 1-7. http://dx.doi.org/10.1097/00005792-199401000-00001
|
[3]
|
Rapoport, B., Alsabeh, R., Aftergood, D. and McLachlan, S.M. (2000) Elephantiasic Pretibial Myxedema: Insight into and a Hypothesis Regarding the Pathogenesis of the Extrathyroidal Manifestations of Graves’ Disease. Thyroid, 10, 685-692. http://dx.doi.org/10.1089/10507250050137761
|
[4]
|
Heyes, C., Nolan, R., Leahy, M. and Gebauer, K. (2012) Treatment-Resistant Elephantiasic Thyroid Dermopathy Responding to Rituximab and Plasmapheresis. Australasian Journal of Dermatology, 53, e1-e4.
http://dx.doi.org/10.1111/j.1440-0960.2010.00693.x
|
[5]
|
Yu, H., Jiang, X., Pan, M. and Huang, R. (2014) Elephantiasic Pretibial Myxoedema in a Patient with Graves’ Disease That Resolved after 131I Treatment. Clinical Nuclear Medicine, 39, 758-759.
http://dx.doi.org/10.1097/RLU.0000000000000459
|
[6]
|
Susser, W.S., Heermans, A.G., Chapman, M.S. and Baughman, R.D. (2002) Elephantiasic Pretibial Myxedema: A Novel Treatment for an Uncommon Disorder. Journal of the American Academy of Dermatology, 46, 723-726.
http://dx.doi.org/10.1067/mjd.2002.119655
|
[7]
|
Dhaille, F., Dadban, A., Meziane, L., Fessier, C., Colta, L., Lok, C., et al. (2012) Elephantiasic Pretibial Myxoedema with Upper-Limb Involvement, Treated with Low-Dose Intravenous Immunoglobulins. Clinical and Experimental Dermatology, 37, 307-308. http://dx.doi.org/10.1111/j.1365-2230.2011.04175.x
|